Page 3 - Ongoing Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomCity ofKristenk sheppardUpcoming program milestonesExchange commissionEuropean association for haemophiliaHemophilia programLockbody technology platformResearch development expensesDrug administrationOrexin agonist programTechnology platformCentessa pharmaceuticalsAgonist programOngoing phase

Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesJon congletonTom weibleTanabe pharmaCatalys pacificExchange commissionElixir health public relationsDrug administrationMineralys therapeutics incUs centers for diseaseTherapeutics reports first quarterProvides corporateOngoing phaseMineralys therapeuticsChief executive officerClinical highlights

Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress

Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of california san franciscoJay fishmanSteve perrinRoslyn mannonFlavio vincentiDiane cibrikKlemens buddeStephen jasperAllan kirkDuke university school of medicineAmerican transplant congressEledon pharmaceuticals incBerry company public relationsUniversity of nebraska medical centerUniversity of kansas health system

Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress - Eledon Pharma (NASDAQ:ELDN)

Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress - Eledon Pharma (NASDAQ:ELDN)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of california san franciscoAllan kirkJay fishmanSteve perrinKlemens buddeRoslyn mannonStephen jasperDiane cibrikFlavio vincentiUniversity of nebraska medical centerEledon pharmaceuticalsAmerican transplant congressUniversity of kansas health systemGilmartin groupBerry company public relations

EyeDNA Therapeutics Announces Positive 24-month Data Presented at ARVO from Ongoing Phase I/II Trial of HORA-PDE6b Gene Therapy in Patients with Retinitis Pigmentosa Caused by Bi-allelic Mutations in PDE6b

EyeDNA Therapeutics Announces Positive 24-month Data Presented at ARVO from Ongoing Phase I/II Trial of HORA-PDE6b Gene Therapy in Patients with Retinitis Pigmentosa Caused by Bi-allelic Mutations in PDE6b
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Franche comtérFrance generalSouth koreaJean baptiste ducloyerSylvie berrebiLeila adlamNantes university department of ophthalmologyAssociation for researchAnnounces positiveData presentedOngoing phaseGene therapyRetinitis pigmentosa causedBi allelic mutationsCoave therapeuticsBest corrected visual acuity